Aligned Genetics
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Aligned Genetics makes laboratory instruments for life-science research and diagnostics, including automated cell counters, biological-tissue clearing and imaging systems, and digital cell imaging systems that replace traditional analogue microscopes.
Its customers span research laboratories, academic institutions, and healthcare organisations worldwide. Listed on KOSDAQ, Korea's tech-focused small-cap exchange, the company offers three distinct product lines that together cover cell analysis, three-dimensional tissue imaging, and digital microscopy.
Summary is AI-generated and may contain errors · figures from DART filings
Aligned Genetics in five facts
What does Aligned Genetics do?
Aligned Genetics makes laboratory instruments for life-science research and diagnostics, including automated cell counters, biological-tissue clearing and imaging systems, and digital cell imaging systems that replace traditional analogue microscopes.
Where is Aligned Genetics listed and in which sector?
Aligned Genetics (Korean name: 얼라인드) trades under KRX code 238120 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Information Technology sector, Components.
How large is Aligned Genetics?
Its market capitalisation was US$27.4M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Aligned Genetics's latest annual revenue and operating profit?
For fiscal year 2025, Aligned Genetics reported revenue of US$12.1M, operating profit of US$1.8M and net income of US$2.2M, per its annual report on DART (data retrieved from DART on 2026-09-18). Revenue was up 1.5% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-18
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Treasury share disposal: results report
Aligned Genetics Co., Ltd. reports disposal of 114,000 common treasury shares to employees and executives as restricted share awards (RSA), executed on June 23, 2026 at a closing price of US$2.20 per share for a total of US$251K, against a planned disposal of 160,000 shares; after disposal the company holds 46,000 treasury shares (0.32% of shares outstanding).
Treasury Shares · Sep 3 - [Amended] Material event report (treasury share disposal)
Aligned Genetics updated a disclosed plan to sell treasury shares worth US$385K, about 1.6% of its market value.
Treasury Shares · Jun 30 · 2 versions